Compare Fiserv Inc. Common Stock (FISV) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fiserv Inc. Common Stock vs uniQure N.V. Ordinary Shares — how do they compare? Fiserv Inc. Common Stock trades at $45.88 (market cap $24.50B), while uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.45B). The key difference: Fiserv Inc. Common Stock is far larger — about 16.9× uniQure N.V. Ordinary Shares's market cap, and uniQure N.V. Ordinary Shares is trading nearer its 52-week high, Fiserv Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Fiserv Inc. Common Stock for 0 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| FISV | QURE | |
|---|---|---|
Market Cap | $24.50B | $1.45B |
Volume | 3,682,634 | 3,323,243 |
Sector | Technology | Health |
52-Week High | $126.54 | $70.59 |
52-Week Low | $44.36 | $9.03 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $52.29B | $707.46M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Fiserv Inc. Common Stock
Fiserv, Inc. is a global provider of payments and financial services technology, offering merchant acquiring, digital commerce, and financial solutions through its Merchant Solutions and Financial Solutions segments.
Read more on FISV →About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →
